Sterility Testing Market: Global Industry Analysis and Opportunity Assessment 2020-2025  

Global Sterility Testing Market is valued at USD 657.1 Million in 2018 and expected to reach USD 1470.8 Million by 2025 with the CAGR of 12.2% over the forecast period.

Increasing the growth of the pharmaceutical and biotechnology industries and surge in advanced new drugs are the major factors expected to drive the growth of the Global Sterility Testing Market.

Get Sample of This Report@

Scope of Global Sterility Testing Market Report–

Sterility Testing is a testing which confirms that products are free from the presence of viable microorganisms. Sterility testing is important for medical devices, pharmaceuticals, preparations, tissue materials and other materials that claim to be sterile or free from viable microorganisms. Sterility also depends on procedural methods that effectively prevent contamination of biological materials like clean room technology and other good manufacturing practices. Tests for viral contaminants, which are normally laid out in individual product requirements, are more complex and expensive. According to world health organization, the sterility testing procedures are applicable across a good range of biological medicinal products including vaccines, blood products, biotechnology products and cell and tissue products.

Global Sterility Testing market Report covers prominent players are like,

SGS, Charles River Laboratories, Thermo Fisher Scientific, bioMerieux, Merck KgaA, Boston Analytical, Molecular

The regions covered in this global sterility testing market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level market of sterility testing is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Increasing Growth of Pharmaceutical and Biotechnology Industries and Surge in Advanced New Drugs are the Major Factors Expected to Drive the Growth of Global Sterility Testing Market.

Growth of pharmaceutical & biotechnology companies and increasing number of drug launches are the factors which are expected to drive the growth of sterility testing Market. Biotechnology has emerged as an important growth sector in pharmaceuticals. Pharmaceutical companies have made increasing use of biotechnology in discovering and manufacturing new medicines. In 2018, the funding for biotech ventures was at its highest, compared to previous years. According to statistics biotechnology, funding for startups was at USD 8 billion in 2018, compared to USD 4 billion in 2017.

The investment in biotechnology statistics shows that biotechnology markets are increasing worldwide. According to the 2015 Organization for Economic Co-operation and Development (OECD) report on biotechnology statistics; the U.S. has 11,367 biotech firms followed by 2,831 in Spain and 1,950 in France. Growing approvals from the regulatory bodies are surging the launch of new drugs and several products, which is also expected to fuel the market in the coming years. According to Chemical & Engineering News, although pharmaceutical companies last year were unable to top the record-shattering 59 new drugs approved in the U.S. in 2018, they were still on a roll. In 2019, the Food and Drug Administration in North America, The 48 medicines represent another highly productive year for the pharmaceutical industry, with cancer and rare-disease drugs.

Global Sterility Testing Market Segmentation:–

By Product Types: Direct Inoculation, Membrane Filtration, Others

By Applications: Medical, Pharmaceutical, Biological, Others

North America is Expected to Dominate the Global Sterility Testing Market

North America is expected to dominate the global sterility testing market owing to the increasing government support for pharmaceutical and biotechnology industries and rising demand for sterilized products in this region. The government is taking a number of initiatives to help pharma companies and up gradation assistance scheme to support the pharma industry. According to biotechnology industry data survey, the Canadian biotechnology sector has an aggressive R&D agenda and high expectations for bringing new products to market over the coming years. In 2017, a majority (54%) of respondents identified their companies as operating at an emerging phase of development, while 22% identified themselves in the growth phase. Europe is the second largest region in this market due to the increasing R&D investment in life sciences in this region.

Full Research Report @

About us: Brandessence Market Research and Consulting Pvt. Ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals, and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations, and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us at: +44-2038074155 or mail us at








Comments are closed